UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 1.940

Sortiert nach

Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis

Renal failure, 2024-12, Vol.46 (1), p.2349114-2349114

2024

Volltextzugriff (PDF)

Long-term effectiveness and safety of edoxaban in patients with atrial fibrillation: 4-year data from the ETNA-AF-Europe study

International journal of cardiology, 2024-08, Vol.408, p.132118, Article 132118

2024

Volltextzugriff (PDF)

Relative performance evaluation of four bleeding risk scores in atrial fibrillation patients. What does the new DOAC score provide?

International journal of cardiology, 2024-07, Vol.407, p.132018-132018, Article 132018

2024

Volltextzugriff (PDF)

Use of apixaban in adults with congenital heart disease and atrial arrhythmias: The PROTECT-AR study

International journal of cardiology, 2024-07, Vol.406, p.131993, Article 131993

2024

Volltextzugriff (PDF)

Common P-glycoprotein ( ABCB1 ) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events: Preliminary data

Biochemia Medica, 2024-06, Vol.34 (2), p.020703-020703

2024

Volltextzugriff (PDF)

Risk of stroke in patients with prior VKA or DOAC: A population-based real-world registry analysis

European stroke journal, 2024-06, Vol.9 (2), p.418-423

2024

Volltextzugriff (PDF)

Comparison of different direct oral anticoagulant regimens in atrial fibrillation patients with high bleeding risk

Heart rhythm, 2024-06, Vol.21 (6), p.715-722

2024

Volltextzugriff (PDF)

Andexanet alfa versus non-specific treatments for intracerebral hemorrhage in patients taking factor Xa inhibitors — Individual patient data analysis of ANNEXA-4 and TICH-NOAC

International journal of stroke, 2024-06, Vol.19 (5), p.506-514

2024

Volltextzugriff (PDF)

Comparison of direct oral anticoagulants and warfarin in chronic limb-threatening ischemia

Journal of vascular surgery, 2024-06, Vol.79 (6), p.1466-1472.e1

2024

Volltextzugriff (PDF)

Peak plasma anti-Xa direct oral anticoagulant levels after gastrointestinal surgeries: A retrospective cohort

Thrombosis research, 2024-06, Vol.238, p.85-87

2024

Volltextzugriff (PDF)

Direct Oral Anticoagulants: Navigating Through Clinical Challenges

Cardiovascular drugs and therapy, 2024-06, Vol.38 (3), p.637-650

2024

Volltextzugriff (PDF)

Unfractionated Heparins, Low-Molecular-Weight Heparins, and Indirect Factor Xa Inhibitors in Plastic and Reconstructive Surgery: An Evidence-Based Review

Plastic and reconstructive surgery (1963), 2024-06, Vol.153 (6), p.1224e

2024

Volltextzugriff (PDF)

Reversal or Repletion Treatment Strategies and Outcomes of Patients With Major Bleeding Events Managed in the Emergency Department: Large Real-Life Investigation in the Northwestern Healthcare District of Tuscany

Critical pathways in cardiology, 2024-06, Vol.23 (2), p.58

2024

Volltextzugriff (PDF)

Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes

The Annals of pharmacotherapy, 2024-06, Vol.58 (6), p.572

2024

Volltextzugriff (PDF)

Extending venous thromboembolism secondary prevention with apixaban in cancer patients. The EVE trial

Journal of thrombosis and haemostasis, 2024-06, Vol.22 (6), p.1704-1714

2024

Volltextzugriff (PDF)

PrevAleNce and Associated factors of inappropriaTe dosing of direct Oral anticoaguLants In pAtients with Atrial Fibrillation: the ANATOLIA-AF Study

Cardiovascular drugs and therapy, 2024-06, Vol.38 (3), p.581-599

2024

Volltextzugriff (PDF)

Uninterrupted direct-acting oral anticoagulation in patients undergoing transradial percutaneous coronary procedures: The DOAC-NOSTOP study rationale and design

Cardiovascular revascularization medicine, 2024-06, Vol.63, p.68-72

2024

Volltextzugriff (PDF)

Comparative Safety and Effectiveness of Reduced Doses of Direct Acting Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation

The American journal of medicine, 2024-06, Vol.137 (6), p.520-528.e13

2024

Volltextzugriff (PDF)

DOACs for Older adults with Atrial Fibrillation and Falls: Results from the prospective single-centre DOAFF study

Thrombosis research, 2024-06, Vol.238, p.78-84

2024

Volltextzugriff (PDF)

Role of Clinical Pharmacy anticoagulation service on Apixaban prescribing appropriateness in atrial fibrillation in Saudi Arabia

Current problems in cardiology, 2024-06, Vol.49 (6), p.102517, Article 102517

2024

Volltextzugriff (PDF)

Effect of low- versus high-dose 4-factor prothrombin complex concentrate in factor Xa inhibitor-associated bleeding: A qualitative systematic review

American journal of health-system pharmacy, 2024-05, Vol.81 (11), p.e274-e282

2024

Volltextzugriff (PDF)

Comparison of apixaban versus aspirin for the prevention of latent bioprosthetic aortic valve thrombosis: study protocol for a prospective randomized trial

Trials, 2024-05, Vol.25 (1), p.324-324, Article 324

2024

Volltextzugriff (PDF)

Reversing Oral Anticoagulation in Intracerebral Hemorrhage

The New England journal of medicine, 2024-05, Vol.390 (19), p.1815

2024

Volltextzugriff (PDF)

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage

The New England journal of medicine, 2024-05, Vol.390 (19), p.1745

2024

Volltextzugriff (PDF)

Safety and Efficacy of Direct Oral Anticoagulants vs Warfarin in Patients With Obesity and Venous Thromboembolism: A Retrospective Analysis

Texas Heart Institute journal, 2024-05, Vol.51 (1), p.1-7

2024

Volltextzugriff (PDF)

1 – 25 von 1.940

Suche als RSS-Feed

Aktive Filter

SpracheDänisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.805)
Mit Volltextzugriff
(1.417)

Publikationsform

Sprache

9 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Humans
(1.889)
Science & Technology
(1.681)
Life Sciences & Biomedicine
(1.660)
Factor Xa Inhibitors - Adverse Effects
(983)
Male
(923)
Anticoagulants - Adverse Effects
(900)
Female
(866)
Cardiovascular System & Cardiology
(802)
Hemorrhage - Chemically Induced
(749)
Aged
(720)
Factor Xa Inhibitors
(637)
Middle Aged
(620)
Anticoagulants
(606)
Treatment Outcome
(538)
Administration, Oral
(523)
Factor Xa Inhibitors - Therapeutic Use
(510)
Rivaroxaban
(509)
Anticoagulants - Therapeutic Use
(503)
Factor Xa Inhibitors - Administration & Dosage
(470)
Cardiac & Cardiovascular Systems
(459)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.934)
RCN full-text journals@Ovid
(1.039)
Ingenta
(782)
EZB Electronic Journals Library
(756)
IngentaConnect Journals
(493)
NUS Single-Journal Subscriptions
(428)
ScienceDirect
(369)
Wiley-Blackwell Journals
(283)
Springer journals
(233)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(231)
Wiley Online Library
(209)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(145)
Thieme_化学药学期刊
(122)
Sage Journals
(89)
Access via Taylor & Francis
(86)
Taylor & Francis
(74)
Oxford Journals
(73)
Oxford Journals 2020 Medicine
(68)
Taylor & Francis Journals Complete
(50)
Nexis Uni (LexisNexis)
(47)

15 weitere anzeigen...

Weniger anzeigen...